PHASE I CLINICAL EVALUATION OF CNSA-001 (SEPIAPTERIN), A NOVEL PHARMACOLOGICAL TREATMENT FOR PHENYLKETONURIA AND TETRAHYDROBIOPTERIN DEFICIENCIES, IN HEALTHY VOLUNTEERS

Smith Neil; Longo Nicola; Blau Nenad

首页> 外文期刊>Molecular genetics and metabolism >PHASE I CLINICAL EVALUATION OF CNSA-001 (SEPIAPTERIN), A NOVEL PHARMACOLOGICAL TREATMENT FOR PHENYLKETONURIA AND TETRAHYDROBIOPTERIN DEFICIENCIES, IN HEALTHY VOLUNTEERS

【24h】

PHASE I CLINICAL EVALUATION OF CNSA-001 (SEPIAPTERIN), A NOVEL PHARMACOLOGICAL TREATMENT FOR PHENYLKETONURIA AND TETRAHYDROBIOPTERIN DEFICIENCIES, IN HEALTHY VOLUNTEERS

机译：I阶段CNSA-001（Sepiapterin）的临床评价，一种新的苯丙酮尿和四氢替替替林缺乏的新药治疗，在健康的志愿者中

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Molecular genetics and metabolism》 |2019年第3期|共1页
作者
Smith Neil; Longo Nicola; Blau Nenad;
展开▼
作者单位

Censa Pharmaceut Inc Wellesley MA USA;

Univ Utah Hlth Dept Pediat Div Med Genet Salt Lake City UT USA;

Univ Childrens Hosp Dietmar Hopp Metab Ctr Heidelberg Germany;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类内分泌腺疾病及代谢病;
关键词

相似文献

外文文献
中文文献
专利

1. PHASE I CLINICAL EVALUATION OF CNSA-001 (SEPIAPTERIN), A NOVEL PHARMACOLOGICAL TREATMENT FOR PHENYLKETONURIA AND TETRAHYDROBIOPTERIN DEFICIENCIES, IN HEALTHY VOLUNTEERS [J] . Smith Neil, Longo Nicola, Blau Nenad Molecular genetics and metabolism . 2019,第3期

机译：I阶段CNSA-001（Sepiapterin）的临床评价，一种新的苯丙酮尿和四氢替替替林缺乏的新药治疗，在健康的志愿者中
2. Phase I clinical evaluation of CNSA-001 (sepiapterin), a novel pharmacological treatment for phenylketonuria and tetrahydrobiopterin deficiencies, in healthy volunteers [J] . Neil Smith, Nicola Longo, Keith Levert, Molecular genetics and metabolism . 2019,第4期

机译：I阶段CNSA-001（Sepiapterin）的临床评价，一种新的苯丙酮尿和四氢替替替林缺乏的新药治疗，在健康的志愿者中
3. PHASE I CLINICAL EVALUATION OF CNSA-001 (SEPIAPTERIN), A NOVEL PHARMACOLOGICAL TREATMENT FOR PHENYLKETONURIA AND TETRAHYDROBIOPTERIN DEFICIENCIES, IN HEALTHY VOLUNTEERS [J] . Smith Neil, Longo Nicola, Blau Nenad Molecular genetics and metabolism . 2019,第3期

机译：I阶段CNSA-001（Sepiapterin）的临床评价，一种新的苯丙酮尿和四氢替替替林缺乏的新药治疗，在健康的志愿者中
4. Arterial Blood Pressure Estimation Using Ultrasound: Clinical Results on Healthy Volunteers and a Medicated Hypertensive Volunteer [C] . Aaron M. Zakrzewski, Brian W. Anthony Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2017

机译：超声动脉血压估计：健康志愿者和药物高血压志愿者的临床结果
5. Evaluation of Skin Tape Stripping in Healthy Human Volunteers as a Methodology for Quantifying Local Drug Bioavailability from Dermal Products [D] . Shukla, Sagar. 2020

机译：评估健康人类志愿者的皮肤胶带剥离作为定量皮肤产品的局部药物生物利用度的方法
6. Exploratory study of the effect of one week of orally administered CNSA-001 (sepiapterin) on CNS levels of tetrahydrobiopterin dihydrobiopterin and monoamine neurotransmitter metabolites in healthy volunteers [O] . Neil Smith, Nicola Longo, Keith Levert, 2019

机译：在健康志愿者中口服一周一次的CNSA-001（sepapterin）对中枢神经系统中四氢生物蝶呤二氢生物蝶呤和单胺类神经递质代谢产物影响的探索性研究
7. Exploratory study of the effect of one week of orally administered CNSA-001 (sepiapterin) on CNS levels of tetrahydrobiopterin, dihydrobiopterin and monoamine neurotransmitter metabolites in healthy volunteers [O] . Neil Smith, Nicola Longo, Keith Levert, 2019

机译：一周对口服施用CNSA-001（SepiaPterin）对健康志愿者中CNS水平，二氢肝素和单胺神经递质代谢物的探索性研究

PHASE I CLINICAL EVALUATION OF CNSA-001 (SEPIAPTERIN), A NOVEL PHARMACOLOGICAL TREATMENT FOR PHENYLKETONURIA AND TETRAHYDROBIOPTERIN DEFICIENCIES, IN HEALTHY VOLUNTEERS

著录项

相似文献

相关主题

期刊订阅